麻豆传媒

Phase II data pave path toward registration trial

Study suggests remission should be sole target, even if most patients can't reach it

Is this the final finding from ORAL Surveillance? Don't count on it.

Accuracy above 85% in early testing -- far better than proteinuria and biopsy

Physical therapy for meniscal tears clearly helps, but new study points to a placebo effect

Negative studies of colchicine and herbal-supplement cocktail dash some hopes

Claims data show it works and doesn't cause lupus flares

At least modestly effective, phase III data show

Phase III results, now published, should support approval

Liposomal formulation OK for repeat dosing, phase III study indicates

Mechanism different from currently available therapies

Worries about vaccine responsiveness relieved; Big Pharma gets interested

Computer matches live expert in measuring joint space and erosions

More phase II data build case for izokibep